ARTICLE | Company News
GeneMedicine, Corange Ltd. deal
February 12, 1996 8:00 AM UTC
Corange invested $4 million through the purchase of 418,629 GMED shares at $9.56 per share, a 20 percent premium to the 15-day average market price of the stock. GMED closed at $8.375 on Friday. ...